Skip to main content
Toggle navigation
Login
Search
Home
Official Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
On Demand
In-Person
Livestream
Invite Only
Ticketed
Coffee Break
Meal
Reception
Favorite
Greg Sullivan, MD
Chief Medical Officer
Tonix Pharmaceuticals, Inc.
Poster(s):
Pooled Efficacy From Two Phase 3 Pivotal Trials (RELIEF AND RESILIENT) of TNX-102 SL, Cyclobenzaprine HCl Sublingual Tablets, in Participants with Fibromyalgia
Thursday, October 23, 2025
3:45 PM - 5:00 PM
MT